The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index; 17 of the 25 sources its claims cite were checked for support.
Decision Support and Behavioral Health for Reducing High-Dose Opioids in Comorbid Chronic Pain, Depression and Anxiety: Stepped-Wedge Cluster Randomized Trial
Open accessAbstract
Background: High prevalence of depression or anxiety with opioid use for chronic pain complicates co-management and may influence prescribing behaviors. Objective: Compare clinical effectiveness of electronic medical record clinical decision support (EMR-CDS) versus additional behavioral health (BH) care management for reducing rates of high-dose opioid prescriptions. Design: Type 2 effectiveness-implementation hybrid stepped-wedge cluster randomized trial in 35 primary care clinics within a health system in LA, USA. Participants: Patients aged 18+ receiving chronic opioid therapy for non-cancer pain with depression or anxiety and matched controls. Intervention: EMR-CDS included opioid risk mitigation procedures. BH care included cognitive behavioral therapy; depression or anxiety medication adjustments; and case management. Main Measures: Outcomes of interest included difference-in-difference (DID) estimate of changes in probability for prescribing high-dose morphine equivalent daily dose (MEDD ≥50 mg/day and MEDD ≥90), average MEDD, and rates of hospitalization, emergency department use, and opioid risk mitigation. Key Results: Most participants were female with 3+ pain syndromes. Data analysis included 632 patients. Absolute risk differences for MEDD≥50 and ≥90 decreased post-index compared to pre-index (DID of absolute risk difference [95%CI]: −0.036 [−0.089, 0.016] and −0.029 [−0.060, 0.002], respectively). However, these differences were not statistically significant. The average MEDD decreased at a higher rate for the BH group compared to EMR-CDS only (DID rate ratio [95%CI]: 0.85 [0.77, 0.93]). There were no changes in hospitalization and emergency department utilization. The BH group had higher probabilities of new specialty referrals and prescriptions for naloxone and antidepressants. Conclusions: Incorporation of a multidisciplinary behavioral health care team into primary care did not decrease high-dose prescribing; however, it improved adherence to clinical guideline recommendations for managing chronic opioid therapy for non-cancer pain. Trial Registration: ClinicalTrials.gov ID NCT03889418 © The Author(s), under exclusive licence to Society of General Internal Medicine 2024.
Overview
CoChat Summary
TL;DR
In this stepped-wedge cluster randomized trial across 35 primary care clinics, adding multidisciplinary behavioral health care to EMR clinical decision support did not significantly reduce high-dose opioid prescribing, but it did improve opioid risk-mitigation and some patient symptoms. The average morphine equivalent daily dose (MEDD) fell more in the behavioral health group than in usual care (DID rate ratio 0.85, 95% CI 0.77–0.93).
Key findings
- The study included 632 adults in the final analysis; baseline average MEDD was 47.1 mg/day, 26.9% had MEDD ≥50 mg/day, and 10.3% had MEDD ≥90 mg/day.
- High-dose opioid prescribing did not significantly differ by group: DID for MEDD ≥50 was -0.036 (95% CI -0.089, 0.016) and for MEDD ≥90 was -0.029 (95% CI -0.060, 0.002).
- Average MEDD decreased more in the behavioral health group than in EMR-CDS usual care: DID rate ratio 0.85 (95% CI 0.77, 0.93).
- Behavioral health care had higher probabilities of new specialty referrals and naloxone and antidepressant prescriptions; the paper also reports symptom improvements in the behavioral health group, including PHQ-9 <10 in 62% of those with baseline PHQ-9 ≥10, GAD-7 <10 in 57% with baseline GAD-7 ≥10, PEG-3 down by 1.3 points, and COMM-9 down by 1.1.
Methods
- Type 2 effectiveness-implementation hybrid stepped-wedge cluster randomized trial in 35 primary care clinics within Ochsner Health in Louisiana; five geographic regions were randomized to rollout order in five steps at 3- to 4-month intervals from April 2019 to May 2020.
- Eligible patients were adults 18+ on chronic opioid therapy for non-cancer pain with documented depression or anxiety; 656 were eligible and 632 were included in analysis. Matched controls came from the same health system and were propensity score matched, up to two controls per behavioral health patient.
- Main analyses used generalized linear mixed models with random intercepts for patient and study region and a difference-in-differences framework, with binary MEDD outcomes analyzed via absolute risk differences and continuous service-use/dose outcomes modeled with Poisson or negative binomial distributions as appropriate.
Limitations
- The paper states it was conducted at one institution, limiting external generalizability.
- The authors state causal inferences cannot be drawn because randomization of patients was not practical and matched controls were used instead; they also note possible selection bias among referred/enrolled patients.
- Fourteen behavioral health patients had inaccessible opioid prescription data from outside providers and were excluded from the MEDD analysis; the paper states it cannot determine the direction of bias from this missing data.
- Evident from the text: patient-reported outcomes were not consistently documented as structured data in the usual care arm, so between-group comparison of those outcomes was not possible.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 5 Not checked · 63 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Additionally, existing interventions have not fully addressed determinants of inappropriate prescribing or usage of opioids. 9”
What the sources say
- Supportedcites [9] Moride Y, Lemieux-Uresandi D, Castillon G, et al. A Systematic Review of Interventions and Programs Targeting Appropriate Prescribing of Opioids. Pain Physician. 2019;22(3):229-240. source
The paper’s Additional information section says its review suggests existing interventions have not addressed important determinants of inappropriate opioid prescribing and usage. The cited sentence is a faithful paraphrase of that qualified conclusion. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In the authors' prior study of a provider-targeted electronic medical record clinical decision support (EMR-CDS) for safe opioid prescribing, approximately 30% of patients receiving opioid therapy for chronic pain had documented histories of depression or anxiety. 11”
What the sources say
- Partly supportedcites [11] Price-Haywood EG, Burton J, Burstain T, et al. Clinical Effectiveness of Decision Support for Prescribing Opioids for Chronic Noncancer Pain: A Prospective Cohort Study. Value Health. 2020;23(2):157-163. https://doi.org/10.1016/j.jval.2019.09.2748 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says almost 30% of study patients had a known history of mental health conditions. The Results (page unavailable) describe the documented conditions as depression, anxiety, or substance abuse, so the paper does not establish that approximately 30% specifically had histories of depression or anxiety. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Several studies demonstrate that collaborative interdisciplinary care improves management of depression, anxiety, pain, and substance abuse in primary care. 14-18”
What the sources say
- Partly supportedcites [14] Archer J, Bower P, Gilbody S, et al. Collaborative Care for Depression and Anxiety Problems. Cochrane Database Syst Rev. 2012;10:Cd006525. https://doi.org/10.1002/14651858.CD006525.pub2 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports that collaborative care improves depression and anxiety outcomes compared with usual care. The Characteristics of included studies describe interventions addressing pain and at-risk drinking, but the passages found do not establish improved outcomes for pain or substance abuse. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [15] Butler M, Kane RL, McAlpine D, et al. Integration of Mental Health/substance Abuse and Primary Care. Evid Rep Technol Assess (Full Rep). 2008;(173):1-362.
- Not checked — no full text of the sourcecites [16] Dobscha SK, Corson K, Perrin NA, et al. Collaborative Care for Chronic Pain in Primary Care: a Cluster Randomized Trial. Jama. 2009;301(12):1242-52. https://doi.org/10.1001/jama.2009.377 source
- Partly supportedcites [17] Kroenke K, Bair MJ, Damush TM, et al. Optimized Antidepressant Therapy and Pain Self-management in Primary Care Patients with Depression and Musculoskeletal Pain: A Randomized Controlled Trial. Jama. 2009;301(20):2099-110. https://doi.org/10.1001/jama.2009.723 sourceExperimental — accuracy not yet measured
The Methods describe a nurse care manager supervised by a physician depression specialist, and the Results report improved depression and pain outcomes in primary care patients, with less severe anxiety as a secondary outcome (pages unavailable in our copy). The paper does not report improved management of substance abuse, so it does not support the full list of conditions attributed to it. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [18] Untzer J, Katon W, Callahan CM, et al. Collaborative Care Management of Late-life Depression in the Primary Care Setting: A Randomized Controlled Trial. Jama. 2002;288(22):2836-45. https://doi.org/10.1001/jama.288.22.2836 source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Adults with chronic pain report more severe symptoms of depression or anxiety. 12”
What the sources say
- Supportedcites [12] Mullins PM, Yong RJ, Bhattacharyya N. Associations Between Chronic Pain, Anxiety, and Depression Among Adults in the USA. Pain Pract. 2023;https://doi.org/10.1111/papr.13220 source
The Results report that adults with chronic pain had more severe depressive and anxiety symptoms than those without chronic pain (both p < 0.001). The Discussion likewise reports higher proportions with elevated symptoms in the chronic-pain group. (LLM, conf=0.95)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“we previously reported in an observational study that patients with a history of substance abuse, depression, or anxiety had higher odds of receiving opioid prescriptions with a morphine equivalent daily dose (MEDD) ≥90 mg. 11”
What the sources say
- Supportedcites [11] Price-Haywood EG, Burton J, Burstain T, et al. Clinical Effectiveness of Decision Support for Prescribing Opioids for Chronic Noncancer Pain: A Prospective Cohort Study. Value Health. 2020;23(2):157-163. https://doi.org/10.1016/j.jval.2019.09.2748 source
The Results section, “Factors Associated with Prescribing High-Dose Opioids” (page not provided), reports increased odds of prescriptions with average MEDD ≥90 mg among patients with a substance abuse diagnosis and among those diagnosed with depression and/or anxiety. This matches the attributed claim. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
34 more claims · 2 with their cited sources checked
Create a free account to see all 83 claims and every source verdict.
- Probably not a substantial claim. 29
- It may state two separate claims as one. 19
- Borderline: one of the tests for a substantial claim is unclear. 1
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Trial Design
“This study examines the main objective of a type 2 effectiveness-implementation hybrid stepped-wedge cluster randomized trial conducted in 35 primary care clinics within Ochsner Health in LA, USA.”
§ Usual Care Group
“Randomized sequence of rolling out behavioral health intervention across five geographic regions: April - July 2019, Region I, 14 clinics; July-September 2019, Region II, 6 clinics; October 2019 - December 2019, Region III, 4 clinics; January - March 2020, Region IV, 11 clinics; April - June 2020, Region V, 4 clinics.”
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
An Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ–4
Kroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2009) · Psychosomatics · doi:10.1016/s0033-3182(09)70864-3 · Cited by 4,261
Unützer, J., Katon, W., Callahan, C. M., Williams, Jr., Hunkeler, E., Harpole, L., Hoffing, M., Della Penna, R. D., Noël, P. H., Lin, E. H. B., et al. (2002) · JAMA · doi:10.1001/jama.288.22.2836 · Cited by 2,405
CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7103a1 · Cited by 1,886
Collaborative care for depression and anxiety problems
Archer, J., Bower, P., Gilbody, S., Lovell, K., Richards, D., Gask, L., Dickens, C., & Coventry, P. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006525.pub2 · Cited by 1,126
Webster, L. R., & Webster, R. M. (2005) · Pain Medicine · doi:10.1111/j.1526-4637.2005.00072.x · Cited by 1,096
Krebs, E. E., Lorenz, K. A., Bair, M. J., Damush, T. M., Wu, J., Sutherland, J. M., Asch, S. M., & Kroenke, K. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-0981-1 · Cited by 782
Trends in Opioid Analgesic–Prescribing Rates by Specialty, U.S., 2007–2012
Levy, B., Paulozzi, L., Mack, K. A., & Jones, C. M. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.02.020 · Cited by 723
Cited by
Pelisão, T., da Silva, R. S., Filho, J. E. D. J. D. O., Franco, J. G. M., de Miranda, A. F. G., Favero, M. D., da Silva, R. S., de Sousa, J. F., Lacerda, L. N. D. A., & Souto, K. K. P. (2026) · Cognitus Interdisciplinary Journal · doi:10.71248/t4nwx204
Kedia, S., Sirohi, S., Ahuja, N. A., Entwistle, C., Dillon, P., Mahmood, A., Zhang, H., Chen, S., & Schmidt, M. (2026) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2026.210076
Metadata
- Authors
- Price-Haywood, E. G., Burton, J. H., Harden-Barrios, J., Bazzano, A., Shi, L., Lefante, J., & Jamison, R. N.
- Affiliations
- Ochsner Health System (US)
- Tulane University (US)
- Brigham and Women's Hospital (US)
- Venue
- Journal of General Internal Medicine
- Published
- 2024-08-02
- Volume
- 39
- Issue
- 15
- Pages
- 2952-2960
- ISSN
- 0884-8734 (ISSN-L)
- 1525-1497
- PMC
- PMC11576687
- OpenAlex
- W4401243528
- Cited by
- 2
- References
- 36
- Citations by year
- 2026: 2
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Journal of General Internal Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Funders
- National Institute on Drug Abuse (1R01DA045029)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Health Professions › Health Information Management › Electronic Health Records Systems
- Keywords
- chronic pain, depression, anxiety, clinical decision support, electronic health records, cognitive behavioral therapy, non-cancer pain, primary care, naloxone, antidepressants, hospitalization, emergency department utilization, guideline adherence
- MeSH terms
- Adult, Aged, Analgesics, Opioid, Anxiety, Depression, Female, Humans, Male, Middle Aged, Comorbidity, Cluster Analysis, Decision Support Systems, Clinical, Electronic Health Records, Chronic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Decision Support and Behavioral Health for Reducing High-Dose Opioids in Comorbid Chronic Pain, Depression and Anxiety: Stepped-Wedge Cluster Randomized Trial. https://app.cochat.ai/papers/10.1007/s11606-024-08965-7
- The paper
- Price-Haywood, E. G., Burton, J. H., Harden-Barrios, J., Bazzano, A., Shi, L., Lefante, J., & Jamison, R. N. (2024). Decision Support and Behavioral Health for Reducing High-Dose Opioids in Comorbid Chronic Pain, Depression and Anxiety: Stepped-Wedge Cluster Randomized Trial. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-024-08965-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.